However, Li et al. [35] suggested that positive paxillin expression in ESCC, although significantly higher than normal squamous tissue, had no significant relation to clinicopathological variables and in predicting ESCC prognosis. The gene discussed is PXN; the disease is esophageal squamous cell carcinoma.